Efficacy and Safety of GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus Treatment: Systematic Review

Efficacy and Safety of GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus Treatment: Systematic Review

Introduction: Glucagon-like peptide analogues are a new class of drugs used in the treatment of type 2 diabetes mellitus that mimic the endogenous hormone glucagon-like peptide 1. Glucagon-like peptide 1 regulates glucose levels by stimulating glucose-dependent insulin secretion, suppressing glucago...

Full description

Bibliographic Details
Main Authors: Ana Paula Martins, Rodrigo Miguel Martins Murteira
Format: Article
Language:English
Published: Formifarma, LDA. 2016-04-01
Series:Revista Portuguesa de Farmacoterapia
Subjects:
Diabetes Mellitus
Type 2/drug therapy; Exenatide; Glucagon-Like Peptide 1/therapeutic use; Glucagon-Like Peptide 1/analogs & derivatives; Liraglutide; Safety; Treatment Outcome
Online Access:http://revista.farmacoterapia.pt/index.php/rpf/article/view/116

Internet

http://revista.farmacoterapia.pt/index.php/rpf/article/view/116

Similar Items